BioMarin Pharmaceutical (BMRN)
BioMarin Pharmaceutical Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -23.97M | -26.74M | -17.65M | -5.077M | -4.371M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 11.45M | 10.61M | 10.35M | 9.504M | 9.665M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 12.23M | 11.08M | 19.87M | 13.31M | 13.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 23.68M | 21.69M | 30.23M | 22.81M | 22.96M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -6.877M | 4.871M | -3.712M | -4.171M | -22.09M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -7.171M | -0.175M | 8.861M | 13.57M | -3.499M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -6.179M | -8.68M | -56.39M | -1.91M | -6.241M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 36.22M | 54.77M | -1.933M | 2.616M | 9.21M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 30.04M | -34.91M | -58.32M | 0.706M | 2.969M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -0.25M | -0.355M | -0.053M | -0.156M | -0.315M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | 13.68M | 10.16M | 11.86M | 8.445M | 3.133M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | 0.018M | 0.306M | -4.047M | -0.387M | 0.415M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | 13.45M | 10.11M | 7.758M | 7.902M | 3.233M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | 36.31M | -24.98M | -41.70M | 22.17M | 2.703M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 46.27M | 88.08M | 46.27M | 71.25M | 112.96M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 82.59M | 46.27M | 71.25M | 112.96M | 90.78M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
